SCHEMBL398926

SCHEMBL398926

O=C(O)c1cnccc1N1CCSCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 3/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
KDM6B O15054 1/20 0.41
KDM4A O75164 1/20 0.41
THRB P10828 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4D Q6B0I6 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
F10 P00742 2/20 0.39
PTPN11 Q06124 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
TRPV1 Q8NER1 1/20 0.37
MLYCD O95822 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL394319 0.82 KDM4E (0.47) ALDH1A1MAPTKDM4EKMT2AL3MBTL1
SCHEMBL8696589 0.81 CA12 (0.49) KDM4CALDH1A1MAPTKDM4EMEN1
SCHEMBL4907976 0.81 SMN1; SMN2 (0.50) ALDH1A1MAPTKDM4EL3MBTL1ALOX15
Potassium SCHEMBL30402396 0.80 SMN1; SMN2 (0.49) ALDH1A1MAPTKDM4EL3MBTL1ALOX15
SCHEMBL2122533 0.79 CHIA (0.43) MAPTTRPV1PIM1PIM3
SCHEMBL225760 0.77 ALDH1A1 (0.50) ALDH1A1TDP1L3MBTL1MLYCDALOX15
Biphenyl SCHEMBL27395942 0.76 HTR6 (0.48) ALDH1A1ALOX15CYP3A4PIM1PIM3
SCHEMBL30331023 0.76 F10 (0.39) KDM4CALDH1A1MAPTKDM4EMEN1
SCHEMBL8669300 0.74 GPR119 (0.53) ALDH1A1MAPTMEN1KMT2APTPN11
SCHEMBL19943248 0.73 MAPT (0.55) KDM4CALDH1A1MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408745-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2012-01-25 EP disclosed